SS Innovations Pledges Entire IP Portfolio as Collateral for $20M Convertible Note
SSII is trading near its 52-week low of $2.5 (2.0% above the low).
Summary
SS Innovations closed a $20M secured convertible note with Growth Capital Partners, pledging its entire IP portfolio as collateral. The note converts at 95% of market price with no floor, creating ongoing dilution risk.
Key Events · Financing and Capital Events · SSII
-
$20M Secured Convertible Note Closed
On October 9, 2026, SS Innovations issued a $21,025,000 secured convertible note to Growth Capital Partners for $20,000,000 in cash. The $1,025,000 difference represents a $1M original issue discount and $25K in transaction expenses.
-
Entire IP Portfolio Pledged as Collateral
The note is secured by all of SSI IP Holdings' patents, trademarks, and copyrights—including the SSi Mantra robotic surgery system IP—plus a guaranty from five subsidiaries. The Indian operating subsidiary SSI-India is excluded from collateral.
-
Variable-Price Conversion at 95% of Market
The lender can convert at 95% of the lower of the prior-day VWAP or 5-day average VWAP, with no floor price. Daily conversions are capped at the greater of $50,000 or 10% of daily dollar volume, subject to a 4.99% ownership blocker (expandable to 9.99%).
-
8.75% Interest with Make-Whole Provisions
The note bears 8.75% annual interest compounded daily and matures in 36 months. Any conversion, redemption, or prepayment includes Make-Whole Interest equal to all remaining interest that would have accrued through maturity during year one, declining to 66.66% in year two and 33.33% thereafter.
Analysis · SSII · Industrial Applications And Services
On October 9, 2026, SS Innovations closed a $20 million secured convertible note with Growth Capital Partners. The note carries an 8.75% interest rate, matures in 36 months, and converts at 95% of market price with no floor—a structure that lets the lender convert at a discount and sell into the market. As collateral, the company pledged its entire intellectual property portfolio, including all SSi Mantra robotic surgery patents and trademarks, along with a guaranty from five subsidiaries. This is a high-cost, asset-backed financing that puts the company's core technology at risk if it defaults, while the variable-price conversion creates ongoing dilution pressure on the stock.
How filings like this one have moved
In the 30 days to Nov 4, 2026, 41.5% of the 1196 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, SSII was trading at $2.55 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $511.2M. The 52-week trading range was $2.50 to $10.00. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.